banner 1.jpg

Accelerated drug discovery powered by nature

Pangea Botanica brings the platform business model of company building to nature-inspired drug discovery and development

Our mission is to accelerate the discovery and development of therapeutics inspired by naturally-occurring molecules and traditional remedies, while preserving ethnobotanical knowledge and ecosystems.


Accelerated drug discovery

Pangea brings a higher likelihood of success and reduced timeline in developing new medicines for patients. We optimise our success rates and development time by focusing on nature-inspired compounds with prior evidence of safety and efficacy. 

Focused execution

Our platform operating model enables us to develop multiple products and indications, in an efficient and scalable way. We already have four drug development operating companies, targeting auto-immune, psychiatric, neurodegenerative and neurological indications. Click here for more information on our first operating company, Kanna Health.

Our team has a track record of building companies around natural products and biotech platforms - at COMPASS Pathways (Nasdaq: CMPS); GW Pharmaceuticals (acquired by Jazz Pharmaceuticals); and atai Life Sciences (Nasdaq: ATAI).

Preservation and positive impact

We are committed to preserving ethnobotanical knowledge and habitats, and supporting the communities from which our compounds are derived. 


We want to have a lasting and positive impact on local communities and the environment, as well as on patients, and are applying for B Corp certification. 

light green bubbles.png

Significant untapped potential in nature-inspired drug development


of today's small molecules are nature-inspired


of plant species still 



of nature-derived therapeutics have an ethnomedical use identical or related to the current use


Thanks for submitting! Someone will review your message and contact you as soon as possible.

Sign up to our newsletter to receive updates!

Thanks for your interest!